Jan Alan Alfheim
Chief Executive Officer
Jan A. Alfheim is a business executive with over thirty years of experience bringing product ideas and technology to the chemical and pharmaceutical markets, from product concept inception through discovery and development phases to final marketing campaign and launch. He has direct experience in research, project management, business development & partnering, company start-ups, and product launches. Alfheim comes from Nordic Nanovector ASA where he was Chief Executive Officer from 2011 until 2014 and Chief Operating Officer from 2014 to 2016. Prior to working at Nordic Nanovector, he has held senior roles of increasing importance including Chief Business Officer at Clavis Pharma, President of StemPath Inc, Director of Business Development at Neurochem Inc and Project Director at Nycomed Imaging. Jan A. Alfheim holds a MBA from the University of McGill and a MSc from Concordia University.